Ready-made stem cell therapies for pets could be coming

San Diego startup Gallant has secured $18 million in funding to develop the first FDA-approved ready-to-use stem cell therapy for veterinary medicine. If successful in regulatory approval, this innovation could revolutionize treatments for pets, marking a significant advancement in the experimental field of stem cell research.

Explain It To Me Like I’m 5:

San Diego startup Gallant has raised $18 million to develop the first ready-to-use stem cell therapy for pets, which could change how we treat animals if approved by the FDA.

Want More Context? 🔎